Bummer! Sales have ended.
Unfortunately, tickets for this event are no longer on sale.
Industrial Strength Bio Seminar Series
Monday 6 February 2012
11:30-1P Founders’ Room
Clinical Trials: Why we do them. What we have learned
Alan Miller, MD, PhD
Chief of Oncology, Baylor University Medical Center at Dallas
· The different types of clinical trials and the necessary infrastructure
· Examples of positive and negative trials
· How the nature of clinical trials is changing today
Alan M. Miller, Ph.D., M.D., is the chief of oncology at Baylor University Medical Center at Dallas and for Baylor Health Care System. He also serves as medical director of the Baylor Charles A. Sammons Cancer Center at Dallas. Dr. Miller is an experienced cancer researcher and clinician with a strong administrative background.
Dr. Miller arrived in 2008, shortly after Baylor Dallas announced plans to develop North Texas’ premier cancer hospital and a new outpatient cancer center that will be the largest in the area. The outpatient building opened in March 2011.
“The cancer center provides patient care, education and research,” Dr. Miller said. “It is built around and for the patients, providing outstanding service, surroundings and treatments based on a personalized, precision approach. Treatments are tailored to target the Achilles’ heel of the patient’s cancer, improving effectiveness while minimizing side effects.”
The Innovative Clinical Trials Center, scheduled to open in the summer of 2011, will be a key component in Dr. Miller’s vision to bring the latest in treatment options to Baylor patients.
Dr. Miller came to Dallas from Tulane University Health Sciences Center. He began Tulane’s bone marrow transplant program and held a variety of teaching and leadership roles for 15 years, including associate senior vice president for health sciences and deputy director of the Tulane Cancer Center.
Before joining Tulane, Dr. Miller was an assistant professor of medicine and co-director of the MD/PhD. program at the University of Florida College of Medicine. Dr. Miller earned his master’s and doctorate degrees in physiology from the State University of New York in Buffalo. After serving as an assistant professor of oncology at the University of Miami School of Medicine, Dr. Miller earned his medical degree from Miami and completed his internship, residency and fellowship at Florida. Dr. Miller’s clinical and research areas of specialty are blood and marrow transplant and the hematologic malignancies.